跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
诺泽 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Recombinant Human Somatropin Injection
Approved
生物制品
Recombinant Human Somatropin Injection
Novo Nordisk A/S
🇨🇳 National Medical Products Administration
Approval Date
Oct 29, 2019
Approval ID
7MazXcYG4RC
Company
Novo Nordisk A/S
Type
生物制品
Approval Details
Approval Id
7MazXcYG4RC
Approval Number
S20191002
Generic Name
人生长激素注射液
Generic Name En
Recombinant Human Somatropin Injection
Trade Name
诺泽
Drug Type
生物制品
Dosage Form
注射剂
Strength
1.5ml:15mg(NordiFlex)
Reg Date
2019-10-29
Expired Date
2024-10-28
Company Name
Novo Nordisk A/S
Company Address
Novo Alle 1, DK-2880 Bagsvaerd, Denmark
Production Company Name
Novo Nordisk A/S
Production Company Address
Novo Alle 1, DK-2880 Bagsvaerd, Denmark
Company Detail Path
/organization/novo-nordisk-a-s
Production Company Detail Path
/organization/novo-nordisk-a-s
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 29, 2019
Approval ID
7MazXcYG4RC
Type
生物制品
Back to NMPA Approvals